• LAST PRICE
    68.8900
  • TODAY'S CHANGE (%)
    Trending Down-3.5100 (-4.8481%)
  • Bid / Lots
    68.8100/ 2
  • Ask / Lots
    68.9300/ 1
  • Open / Previous Close
    71.0900 / 72.4000
  • Day Range
    Low 68.8400
    High 71.9700
  • 52 Week Range
    Low 32.9600
    High 195.9900
  • Volume
    352,293
    below average

Search Criteria

Filter search criteria using below inputs

Click on magnifying glass icon to search

Search Criteria - - - Stocks (0)
CompanyCountrySymbol
Select an index
Price Comparison Graph. See accessible table below
1 Day Comparison Chart Accessibility Table. Thursday's close: 72.4
TimeVolumeMRTX
09:32 ET376271.97
09:34 ET40071.69
09:36 ET120071.39
09:38 ET168171.1713
09:39 ET90071.245
09:41 ET130071.245
09:43 ET485570.895
09:45 ET102270.79
09:48 ET226070.84
09:50 ET474070.62
09:52 ET100070.81
09:54 ET90070.81
09:56 ET600070.64
09:57 ET1877270.6
09:59 ET349370.33
10:01 ET60070.165
10:03 ET150170.21
10:06 ET63369.98
10:08 ET256069.85
10:10 ET120069.682
10:14 ET280069.67
10:15 ET75569.82
10:17 ET580969.88
10:19 ET132569.9
10:21 ET147170.11
10:24 ET139170.64
10:26 ET20070.65
10:28 ET130670.785
10:30 ET209270.49
10:32 ET38470.71
10:33 ET41970.76
10:35 ET91870.66
10:37 ET20070.605
10:39 ET120770.35
10:42 ET228670.8
10:44 ET90070.99
10:46 ET270070.89
10:48 ET40071.02
10:50 ET97870.94
10:51 ET256270.83
10:53 ET20070.92
10:55 ET70071.05
10:57 ET183770.93
11:00 ET103870.76
11:02 ET330570.84
11:04 ET194771.01
11:06 ET112571.1
11:08 ET162670.88
11:09 ET322971.1
11:11 ET144371.48
11:13 ET183071.44
11:15 ET80071.5
11:18 ET181471.51
11:20 ET241771.185
11:22 ET20071.215
11:24 ET52371.185
11:26 ET177571.025
11:27 ET163270.9
11:29 ET193970.8
11:31 ET40070.69
11:33 ET140870.69
11:36 ET143570.635
11:38 ET143970.8
11:40 ET104570.765
11:42 ET90070.9
11:44 ET156870.92
11:45 ET72370.905
11:47 ET160170.8
11:49 ET141270.71
11:51 ET81270.76
11:54 ET130070.81
11:56 ET130070.815
11:58 ET40070.8
12:00 ET124870.79
12:02 ET92270.73
12:03 ET50070.68
12:05 ET139970.64
12:07 ET110070.62
12:09 ET53870.4957
12:12 ET212370.46
12:14 ET50070.42
12:16 ET113370.17
12:18 ET610070.155
12:20 ET235770.26
12:21 ET110870.37
12:23 ET20070.22
12:25 ET34370.14
12:27 ET481469.725
12:30 ET141069.71
12:32 ET30069.69
12:34 ET94469.685
12:36 ET40069.59
12:38 ET754669.595
12:39 ET205569.76
12:41 ET40069.81
12:43 ET50069.8
12:45 ET108769.94
12:48 ET70069.96
12:52 ET42270.015
12:54 ET57170.04
12:56 ET30070.02
12:57 ET54469.88
12:59 ET94969.959
01:01 ET58369.88
01:03 ET20069.71
01:06 ET256469.64
01:08 ET300069.625
01:10 ET343569.56
01:12 ET307269.49
01:14 ET185669.5275
01:15 ET72669.53
01:17 ET129669.53
01:19 ET333169.655
01:21 ET110869.47
01:24 ET84669.375
01:26 ET84669.49
01:28 ET148369.51
01:30 ET100069.525
01:32 ET75269.41
01:33 ET30069.395
01:35 ET70069.29
01:37 ET34469.36
01:39 ET166369.31
01:42 ET191969.4
01:44 ET10069.395
01:46 ET140069.42
01:48 ET96969.37
01:50 ET102569.225
01:51 ET20069.18
01:53 ET40069.135
01:55 ET252469.095
01:57 ET63368.97
02:02 ET193268.94
02:04 ET50069.01
02:06 ET42468.95
02:08 ET64368.99
02:09 ET20068.91
02:11 ET703568.86
02:13 ET132068.93
02:15 ET56268.95
02:18 ET20068.89
Data delayed at least 15 minutes.
Industry Peers Overview Table
Company sortableMarket Cap sortableP/E Ratio (TTM) sortableEPS Growth (5yr) sortable
United StatesMRTX
Mirati Therapeutics Inc
3.9B
-5.8x
---
United StatesDNLI
Denali Therapeutics Inc
3.8B
-13.2x
---
United StatesCCXI
ChemoCentryx Inc
3.7B
-27.5x
---
United StatesBPMC
Blueprint Medicines Corp
3.9B
-5.0x
---
United StatesNTLA
Intellia Therapeutics Inc
4.3B
-10.7x
---
United StatesITCI
Intra-Cellular Therapies Inc
4.4B
-13.0x
---
As of 2022-10-07

Company Information

Mirati Therapeutics Inc is a United States-based clinical-stage biotechnology company that is focused on bringing forward therapies that address areas of high unmet need, including lung cancer, and advancing a pipeline of novel therapeutics targeting the genetic and immunological drivers of cancer. The Company is using its scientific expertise to develop novel solutions in two registration-enabling programs: adagrasib (MRTX849), an investigational small molecule, potent and selective KRASG12C inhibitor, as monotherapy and in combination with other agents, and sitravatinib, an investigational spectrum-selective inhibitor of receptor tyrosine kinases in combination with checkpoint inhibitor therapies. The Company is also advancing its differentiated preclinical portfolio, including MRTX1133, an investigational KRASG12D inhibitor, MRTX1719, an investigational PRMT5 inhibitor, and other oncology discovery programs.

Contact Information

Headquarters
3545 Cray CourtSAN DIEGO, CA, United States 92121
Phone
858-332-3410
Fax
302-655-5049

Executives

Lead Independent Chairman of the Board
Faheem Hasnain
President, Founder, Director, Head of Research and Development
Charles Baum
Chief Executive Officer, Director
David Meek
Chief Financial Officer
Laurie Stelzer
Chief Scientific Officer
James Christensen

Our Ratings feature offers company-specific research ratings from providers such as First Call, S&P and Argus.

Open a New Account, or Login if you're a client.

You have access to a comprehensive selection of independent research reports from providers such as TD Securities, S&P, INK, and Argus.

Open a New Account, or Login if you're a client.

Fundamentals Table
Market Cap
$3.9B
Revenue (TTM)
$78.2M
Shares Outstanding
55.6M
Dividend Yield
0.00%
Annual Dividend Rate
---
Ex-Dividend Date
01-01-01
Pay Date
01-01-01
Beta
0.90
EPS
$-11.85
Book Value
$25.24
P/E Ratio
-5.8x
Price/Sales (TTM)
49.7
Price/Cash Flow (TTM)
---
Operating Margin
-816.24%
*GAAP = prior to non-GAAP analyst adjusted earnings.

Our Calendar feature allows you to view a wide selection of market and company events, including earnings, dividends, splits, rating changes, guidance, and more. Access past, current and future events in WebBroker.

Open a New Account, or Login if you're a client.